These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 4055164)

  • 21. Functional and biochemical evidence for the lack of cardiac presynaptic alpha-2 adrenoceptor stimulant properties of cirazoline (LD 3098), a potent alpha-1 adrenoceptor agonist in dogs and rats.
    Cavero I; Lefèvre-Borg F; Roach AG; Gomeni R; Scatton B
    J Pharmacol Exp Ther; 1982 Oct; 223(1):241-50. PubMed ID: 6126583
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Catecholamines and heart function in heart transplant patients: effects of beta1- versus nonselective beta-blockade.
    Leenen FH; Davies RA; Fourney A
    Clin Pharmacol Ther; 1998 Nov; 64(5):522-35. PubMed ID: 9834044
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Central alpha-adrenergic control of blood pressure. Effects of clonidine withdrawal.
    Augustine SJ; Tachikawa S; Lokhandwala MF; Buckley JP
    Chest; 1983 Feb; 83(2 Suppl):328-31. PubMed ID: 6295708
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Abrupt cessation of clonidine administration: a prospective study.
    Whitsett TL; Chrysant SG; Dillard BL; Anton AH
    Am J Cardiol; 1978 Jun; 41(7):1285-90. PubMed ID: 665535
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Withdrawal of antihypertensive therapy. Hypertensive crisis in renovascular hypertension.
    Strauss FG; Franklin SS; Lewin AJ; Maxwell MH
    JAMA; 1977 Oct; 238(16):1734-6. PubMed ID: 578267
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Relationship between sympathetic activity and response to treatment with atenolol in hypertensive patients. Investigation group of the study of efficiency and tolerance of atenolol in hypertensive patients with increase in the sympathetic activity].
    de la Sierra A
    Med Clin (Barc); 1999 Jun; 113(2):41-5. PubMed ID: 10425617
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preliminary trial of the noradrenergic agonist clonidine in psychiatric patients.
    Jimerson DC; Post RM; Stoddard FJ; Gillin JC; Bunney WE
    Biol Psychiatry; 1980 Feb; 15(1):45-57. PubMed ID: 7357058
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological, hemodynamic and autonomic nervous system mechanisms responsible for the blood pressure and heart rate lowering effects of pergolide in rats.
    Cavero I; Lefevre-Borg F; Lhoste F; Sabatier C; Richer C; Giudicelli JF
    J Pharmacol Exp Ther; 1984 Mar; 228(3):779-91. PubMed ID: 6707926
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Withdrawal syndrome following cessation of antihypertensive drug therapy.
    Karachalios GN; Charalabopoulos A; Papalimneou V; Kiortsis D; Dimicco P; Kostoula OK; Charalabopoulos K
    Int J Clin Pract; 2005 May; 59(5):562-70. PubMed ID: 15857353
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of the alpha 1-receptor blocker prazosin and the beta 1-receptor blocker acebutolol and their combination on blood pressure and pressure rate product. Ergometric studies of hypertensive patients].
    Franz IW
    Z Kardiol; 1984 Jan; 73(1):21-8. PubMed ID: 6367245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of clonidine withdrawal: possible mechanisms and suggestions for management.
    Hunyor SN; Hansson L; Harrison TS; Hoobler SW
    Br Med J; 1973 Apr; 2(5860):209-11. PubMed ID: 4700009
    [TBL] [Abstract][Full Text] [Related]  

  • 32. One year efficacy and tolerability of clonidine administered by the transdermal route in patients with mild to moderate essential hypertension--a multicentre open label study. The Antihypertensive Patch Italian Study (APIS) Investigators.
    Clin Auton Res; 1993 Dec; 3(6):379-83. PubMed ID: 8193525
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Withdrawal syndrome after continuous infusion of clonidine in the normotensive rat.
    Thoolen MJ; Timmermans PB; Van Zwieten PA
    J Pharm Pharmacol; 1981 Apr; 33(4):232-5. PubMed ID: 6115906
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blood pressure and blood pressure variability following withdrawal of propranolol and clonidine.
    Neusy AJ; Lowenstein J
    J Clin Pharmacol; 1989 Jan; 29(1):18-24. PubMed ID: 2708545
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Involvement of central noradrenergic mechanisms in the rebound hypertension following clonidine withdrawal.
    Augustine SJ; Buckley JP; Tachikawa S; Lokhandwala MF
    J Cardiovasc Pharmacol; 1982; 4(3):449-55. PubMed ID: 6177942
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Withdrawal phenomena in subjects with essential hypertension on clonidine or tiamenidine.
    Hamilton BP; Mersey JH; Hamilton J; Kuzbida G; Pavlis R; Levinson P
    Clin Pharmacol Ther; 1984 Nov; 36(5):628-33. PubMed ID: 6488684
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Symptoms of clonidine withdrawal after 17 days.
    Frolich JC
    N Engl J Med; 1976 Nov; 295(22):1261-2. PubMed ID: 980045
    [No Abstract]   [Full Text] [Related]  

  • 38. Centrally acting alpha-agonists. Mechanisms and their role in the therapy of essential hypertension.
    Aust N Z J Med; 1976 Aug; 6(3 Suppl):98-101. PubMed ID: 1071410
    [No Abstract]   [Full Text] [Related]  

  • 39. Abrupt discontinuation of clonidine therapy.
    Ram CV; Engelman K
    JAMA; 1979 Nov; 242(19):2104-5. PubMed ID: 490793
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Studies on the rebound hypertension after clonidine withdrawal in conscious hypertensive cats, rats, and dogs [proceedings].
    Cavero I; Fénard S; Finch L; Lefevre F; Roach A
    Br J Pharmacol; 1977 Jun; 60(2):288P-289P. PubMed ID: 560235
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.